Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,122,739
-$41,472,591 QoQ
Shares Held
13,442
-74.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#999
of 4,605 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Freestone Grove Partners LP holds $182,044,995 across 6 Drug Manufacturers - General names. LLY ranks #3 (8.9% of the industry book) .
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,122,739 | 13,442 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $57,595,330 | 53,593 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,889,945 | 19,515 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,316,384 | 28,628 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $1,134,068 | 1,469 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||